Cadence Bank’s Zimmer Biomet ZBH Stock Holding History

Cadence Bank’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,620	Closed	-$236K	–	347
2023 Q2	$236K	Hold	1,620	–	–	0.02%	305
2023 Q1	$209K	Hold	1,620	–	–	0.02%	325
2022 Q4	$207K	Buy	+1,620	New	+$188K	0.02%	316

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cadence Bank's ZBH Position: Q3 2023 in Review

Cadence Bank sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,620 shares — an estimated $236K sold.

Cadence Bank first reported a position in ZBH in Q4 2022 and held it in 3 quarters. The position peaked at $236K in Q2 2023. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Cadence Bank reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Cadence Bank sold 1,620 Zimmer Biomet shares in Q3 2023, an estimated $236K.
Cadence Bank first reported a position in Zimmer Biomet in Q4 2022 and held it in 3 quarters.
Cadence Bank's Zimmer Biomet position peaked at $236K in Q2 2023.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Cadence Bank's 13F filing for Q3 2023, filed 13 Nov 2023.